Found: 278
Select item for more details and to access through your institution.
The headache research priorities: Research goals from the American Headache Society and an international multistakeholder expert group.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 8, p. 912, doi. 10.1111/head.14797
- By:
- Publication type:
- Article
Baseline Normative and Test–Retest Reliability Data for Sideline Concussion Assessment Measures in Youth.
- Published in:
- Diagnostics (2075-4418), 2024, v. 14, n. 15, p. 1661, doi. 10.3390/diagnostics14151661
- By:
- Publication type:
- Article
Sustained benefits of onabotulinumtoxinA treatment in chronic migraine: An analysis of the pooled Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) randomized controlled trials.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 7, p. 838, doi. 10.1111/head.14743
- By:
- Publication type:
- Article
Situational prevention: Pharmacotherapy during periods of increased risk for migraine attacks.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 7, p. 859, doi. 10.1111/head.14775
- By:
- Publication type:
- Article
Hypersensitivity to BK<sub>Ca</sub> channel opening in persistent post-traumatic headache.
- Published in:
- Journal of Headache & Pain, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s10194-024-01808-0
- By:
- Publication type:
- Article
Functional impairment of chronic migraine with medication overuse: Secondary analysis from the Medication Overuse Treatment Strategy (MOTS) trial.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 6, p. 632, doi. 10.1111/head.14732
- By:
- Publication type:
- Article
Sustained response to atogepant in episodic migraine: post hoc analyses of a 12-week randomized trial and a 52-week long-term safety trial.
- Published in:
- Journal of Headache & Pain, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s10194-024-01783-6
- By:
- Publication type:
- Article
Female-selective mechanisms promoting migraine.
- Published in:
- Journal of Headache & Pain, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s10194-024-01771-w
- By:
- Publication type:
- Article
Hypersensitivity to PACAP-38 in post-traumatic headache: a randomized clinical trial.
- Published in:
- Brain: A Journal of Neurology, 2024, v. 147, n. 4, p. 1312, doi. 10.1093/brain/awad367
- By:
- Publication type:
- Article
Physical impairment during and between migraine attacks: A daily diary study of patients with chronic migraine.
- Published in:
- Cephalalgia, 2024, v. 44, n. 4, p. 1, doi. 10.1177/03331024241249747
- By:
- Publication type:
- Article
Impact of headache frequency and preventive treatment failure on quality of life, disability, and direct and indirect costs among individuals with episodic migraine in the United States.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 4, p. 361, doi. 10.1111/head.14684
- By:
- Publication type:
- Article
Patient Sex in Prescribing CGRP Receptor Antagonists for Migraine—Reply.
- Published in:
- JAMA Neurology, 2024, v. 81, n. 4, p. 424, doi. 10.1001/jamaneurol.2023.5838
- By:
- Publication type:
- Article
Flortaucipir tau PET findings from former professional and college American football players in the DIAGNOSE CTE research project.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 3, p. 1827, doi. 10.1002/alz.13602
- By:
- Publication type:
- Article
Unraveling the directional relationship of sleep and migraine-like pain.
- Published in:
- Brain Communications, 2024, v. 6, n. 2, p. 1, doi. 10.1093/braincomms/fcae051
- By:
- Publication type:
- Article
Guidelines of the International Headache Society for controlled trials of pharmacological preventive treatment for persistent post-traumatic headache attributed to mild traumatic brain injury.
- Published in:
- Cephalalgia, 2024, v. 44, n. 3, p. 1, doi. 10.1177/03331024241234068
- By:
- Publication type:
- Article
Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex.
- Published in:
- Cephalalgia, 2024, v. 44, n. 3, p. 1, doi. 10.1177/03331024241238153
- By:
- Publication type:
- Article
Blood pressure elevation in erenumab‐treated patients with migraine: A retrospective real‐world experience.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 3, p. 233, doi. 10.1111/head.14679
- By:
- Publication type:
- Article
Flortaucipir tau PET in former American football players.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.077855
- By:
- Publication type:
- Article
White matter hyperintensities: A long‐term consequence of repetitive head impacts?
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.077856
- By:
- Publication type:
- Article
4 Risk Factor and Biomarker Correlates of FLAIR White Matter Hyperintensities in Former American Football Players.
- Published in:
- 2023
- By:
- Publication type:
- Abstract
Hypersensitivity to opening of ATP-sensitive potassium channels in post-traumatic headache.
- Published in:
- Cephalalgia, 2023, v. 43, n. 11, p. 1, doi. 10.1177/03331024231210930
- By:
- Publication type:
- Article
Identification of brain areas in mice with peak neural activity across the acute and persistent phases of post-traumatic headache.
- Published in:
- Cephalalgia, 2023, v. 43, n. 11, p. 1, doi. 10.1177/03331024231217469
- By:
- Publication type:
- Article
Rethinking headache as a global public health case model for reaching the SDG 3 HEALTH by 2030.
- Published in:
- Journal of Headache & Pain, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s10194-023-01666-2
- By:
- Publication type:
- Article
Hemicrania Continua: An Update.
- Published in:
- Current Pain & Headache Reports, 2023, v. 27, n. 10, p. 543, doi. 10.1007/s11916-023-01156-9
- By:
- Publication type:
- Article
Considering Patient Sex in Prescribing CGRP Receptor Antagonists for Short-Term Treatment of Migraine.
- Published in:
- 2023
- By:
- Publication type:
- Opinion
Long‐term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse: A subgroup analysis.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 6, p. 730, doi. 10.1111/head.14536
- By:
- Publication type:
- Article
White matter hyperintensities in former American football players.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 4, p. 1260, doi. 10.1002/alz.12779
- By:
- Publication type:
- Article
Diagnosis, knowledge, perception, and productivity impact of headache education and clinical evaluation program in the workplace at an information technology company of more than 70,000 employees.
- Published in:
- Cephalalgia, 2023, v. 43, n. 4, p. 1, doi. 10.1177/03331024231165682
- By:
- Publication type:
- Article
Chronic pain recruits hypothalamic dynorphin/kappa opioid receptor signalling to promote wakefulness and vigilance.
- Published in:
- Brain: A Journal of Neurology, 2023, v. 146, n. 3, p. 1186, doi. 10.1093/brain/awac153
- By:
- Publication type:
- Article
Evaluation of vascular risk in patients with migraine with and without aura treated with erenumab: Post hoc analysis of pooled long‐term clinical trial data.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 3, p. 418, doi. 10.1111/head.14485
- By:
- Publication type:
- Article
Patient‐reported experiences with migraine‐related cognitive symptoms: Results of the MiCOAS qualitative study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 3, p. 441, doi. 10.1111/head.14484
- By:
- Publication type:
- Article
Management of Trigeminal Autonomic Cephalalgias Including Chronic Cluster: A Review.
- Published in:
- JAMA Neurology, 2023, v. 80, n. 3, p. 308, doi. 10.1001/jamaneurol.2022.4804
- By:
- Publication type:
- Article
Long-term open-label and real-world studies of lasmiditan, ubrogepant, and rimegepant for the acute treatment of migraine attacks.
- Published in:
- Cephalalgia, 2023, v. 43, n. 2, p. 1, doi. 10.1177/03331024221137092
- By:
- Publication type:
- Article
Post hoc analysis of clinical trial data and pharmacokinetic data to assess wearing‐off of erenumab within monthly treatment cycle.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 2, p. 233, doi. 10.1111/head.14403
- By:
- Publication type:
- Article
Neuropsychological test performance of former American football players.
- Published in:
- Alzheimer's Research & Therapy, 2023, p. 1, doi. 10.1186/s13195-022-01147-9
- By:
- Publication type:
- Article
Neuropsychological test performance of former American football players.
- Published in:
- Alzheimer's Research & Therapy, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13195-022-01147-9
- By:
- Publication type:
- Article
The premonitory phase of migraine is due to hypothalamic dysfunction: revisiting the evidence.
- Published in:
- Journal of Headache & Pain, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s10194-022-01518-5
- By:
- Publication type:
- Article
A new flortaucipir PET biomarker based on graph theory for early detection of CTE in former American football players.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.068936
- By:
- Publication type:
- Article
Guidelines of the International Headache Society for Controlled Clinical Trials in Cluster Headache.
- Published in:
- Cephalalgia, 2022, v. 42, n. 14, p. 1450, doi. 10.1177/03331024221120266
- By:
- Publication type:
- Article
Shift in diagnostic classification of migraine after initiation of preventive treatment with eptinezumab: post hoc analysis of the PROMISE studies.
- Published in:
- BMC Neurology, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12883-022-02914-9
- By:
- Publication type:
- Article
Guidelines of the International Headache Society for Clinic-Based Headache Registries, 1 st edition.
- Published in:
- Cephalalgia, 2022, v. 42, n. 11/12, p. 1099, doi. 10.1177/03331024221099035
- By:
- Publication type:
- Article
Preclinical assessment of onabotulinumtoxinA for the treatment of mild traumatic brain injury-related acute and persistent post-traumatic headache.
- Published in:
- Cephalalgia, 2022, v. 42, n. 11/12, p. 1194, doi. 10.1177/03331024221099841
- By:
- Publication type:
- Article
Exploring the neurobiology of the premonitory phase of migraine preclinically – a role for hypothalamic kappa opioid receptors?
- Published in:
- Journal of Headache & Pain, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s10194-022-01497-7
- By:
- Publication type:
- Article
Exploring the association between migraine and atrial fibrillation utilizing a novel artificial intelligence‐ECG algorithm.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Migraine with aura associates with a higher artificial intelligence: ECG atrial fibrillation prediction model output compared to migraine without aura in both women and men.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 8, p. 939, doi. 10.1111/head.14339
- By:
- Publication type:
- Article
Dysregulation of serum prolactin links the hypothalamus with female nociceptors to promote migraine.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Rates of Response to Atogepant for Migraine Prophylaxis Among Adults: A Secondary Analysis of a Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 6, p. e2215499, doi. 10.1001/jamanetworkopen.2022.15499
- By:
- Publication type:
- Article
FollowTheSutures: Piloting a new way to administer onabotulinumtoxinA for chronic migraine.
- Published in:
- Cephalalgia, 2022, v. 42, n. 7, p. 590, doi. 10.1177/03331024211067775
- By:
- Publication type:
- Article
Evaluating the clinical utility of the patient‐identified most bothersome symptom measure from PROMISE‐2 for research in migraine prevention.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 6, p. 690, doi. 10.1111/head.14295
- By:
- Publication type:
- Article
Migrainous infarction of the eye: Two cases of monocular ischemic complications associated with retinal migraine.
- Published in:
- Cephalalgia, 2022, v. 42, n. 6, p. 553, doi. 10.1177/03331024211056286
- By:
- Publication type:
- Article